Capricor Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	105.42	287.85	11.29	14.69	9.6	34.89
Short-Term Investments	173.19	30.28	140.23	24.79	31.82	-
Cash & Short-Term Investments	278.61	318.13	151.52	39.49	41.42	34.89
Cash Growth	92.44%	109.96%	283.70%	-4.67%	18.74%	6.79%
Accounts Receivable	-	0.06	10.37	10.37	0.55	0.39
Other Current Assets	4.48	4.75	1.5	1	0.92	1.16
Total Current Assets	283.09	322.94	163.39	50.86	42.89	36.44
Net Property, Plant & Equipment	41.66	31.85	6.87	7.61	6.94	4.62
Other Long-Term Assets	1.53	1.16	0.22	0.27	0.27	0.28
Total Assets	326.28	355.95	170.48	58.73	50.09	41.33
Accounts Payable	3.93	1.65	3.28	6.25	4.92	3.72
Accrued Expenses	10.53	15.56	4.91	-	-	-
Current Portion of Leases	0.84	0.2	0.83	0.75	0.68	0.42
Unearned Revenue	12	12	12	24.27	17.98	-
Other Current Liabilities	6.34	6.42	-	-	-	-
Total Current Liabilities	33.64	35.84	21.03	31.27	23.59	4.13
Long-Term Leases	13.94	14.32	0.62	1.49	1.88	2.45
Other Long-Term Liabilities	-	-	3.38	3.38	12.84	3.38
Total Long-Term Liabilities	13.94	14.32	3.99	4.86	14.72	5.83
Total Liabilities	47.58	50.16	25.02	36.13	38.31	9.96
Common Stock	0.06	0.06	0.05	0.03	0.03	0.02
Additional Paid-in Capital	617.72	610.33	344.22	181.7	148.74	139.4
Accumulated Other Comprehensive Income	-0.25	0.28	1.03	0.24	0.11	-
Retained Earnings	-	-	-	-159.37	-137.08	-108.06
Shareholders' Equity	278.7	305.79	145.46	22.6	11.79	31.37
Total Liabilities & Equity	326.28	355.95	170.48	58.73	50.09	41.33
Total Debt	14.78	14.52	1.45	2.24	2.56	2.87
Net Cash (Debt)	263.83	303.61	150.07	37.25	38.86	32.01
Net Cash Growth	-13.10%	102.32%	302.84%	-4.14%	21.39%	-1.03%
Net Cash Per Share	5.34	6.53	4.26	1.39	1.58	1.39
Book Value	278.7	305.79	145.46	22.6	11.79	31.37
Book Value Per Share	5.64	6.58	4.13	0.84	0.48	1.36
Tangible Book Value	278.7	305.79	145.46	22.6	11.79	31.37
Tangible Book Value Per Share	5.64	6.58	4.13	0.84	0.48	1.36

SEC Filings: 10-K · 10-Q